Emerging therapies for the treatment of pulmonary hypertension.
about
Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension.Endothelin-1 augments Na⁺/H⁺ exchange activity in murine pulmonary arterial smooth muscle cells via Rho kinase.Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertensionCell-specific dual role of caveolin-1 in pulmonary hypertension.VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension.Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice.Role of Hypoxia-Induced Brain Derived Neurotrophic Factor in Human Pulmonary Artery Smooth MusclePPARγ Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21.PDGF enhances store-operated Ca2+ entry by upregulating STIM1/Orai1 via activation of Akt/mTOR in human pulmonary arterial smooth muscle cells.Vascular remodeling in pulmonary hypertension.Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1.Cicletanine stimulates eNOS phosphorylation and NO production via Akt and MAP kinase/Erk signaling in sinusoidal endothelial cells.Adrenomedullin and adrenotensin regulate collagen synthesis and proliferation in pulmonary arterial smooth muscle cellsProstacyclins in pulmonary arterial hypertension: the need for earlier therapy.Lung Circulation.BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit.Cell-based therapies in pulmonary hypertension: who, what, and when?Gene therapy for pulmonary arterial hypertension: is a cure in sight?Pulmonary vascular dysfunction secondary to pulmonary arterial hypertension: Insights gained through retrograde perfusion.YM155, a selective survivin inhibitor, reverses chronic hypoxic pulmonary hypertension in rats via upregulating voltage-gated potassium channels.Expression of peptide fragments from proADM and involvement of mitogen-activated protein kinase signaling pathways in pulmonary remodeling induced by high pulmonary blood flow.
P2860
Q34179857-F397F9B9-FA1E-4887-8D23-1A6980E157B2Q34431049-DF396D5F-30E9-40B2-A1E3-CEEB07066FCBQ34627552-A59FD8CA-28E8-4B9B-B9AA-7C4BB28D9D0BQ35029120-7DE76955-CDC4-4890-BCA4-6F57E5CD5C53Q35533520-337F4E16-EC8C-49A1-8405-9E5EB54CE978Q35572413-AF561E3F-BC89-4A5B-B8F1-07926886CCE4Q35698710-CF6D61D2-E982-4131-B644-0787A1F4AAC7Q35711530-B81A113C-9DB9-4091-925F-8A92D87C2CB9Q35895524-7884F097-15B0-4860-A8B4-64E148CC4D19Q36644607-AD8E4362-7769-495A-87BD-9D694226F440Q36764714-4CFBCD7A-C2B9-4A3F-8176-08105037FDC6Q37051526-1B5246FE-5996-4495-BE19-E68E55CEB041Q37604149-3F27FC91-0DAF-4E7B-8E62-53A48580B3C3Q37860201-627C4CAD-6EE2-4911-BE99-2F8F355135ACQ38804579-45AE5242-CCBC-42E3-9138-D3DA45290758Q38817806-1C059E5B-6521-4872-9DA9-73FB57043EF4Q42201432-5A4CA990-BEDC-40E8-B5DC-5034BEEDF311Q42787352-7885C91D-FD63-4CAE-B1C7-CADBC641F89EQ45866160-374FD799-F30F-4D56-8FE4-67A3D633EAE9Q49975721-E411339B-5F1F-4010-9A6E-B75433C8DD01Q51642340-3B9186AA-EE17-4DDE-AE62-424B7EA5C207Q55058827-20011243-C618-4554-879E-7F5FBE49C2CD
P2860
Emerging therapies for the treatment of pulmonary hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging therapies for the treatment of pulmonary hypertension.
@en
Emerging therapies for the treatment of pulmonary hypertension.
@nl
type
label
Emerging therapies for the treatment of pulmonary hypertension.
@en
Emerging therapies for the treatment of pulmonary hypertension.
@nl
prefLabel
Emerging therapies for the treatment of pulmonary hypertension.
@en
Emerging therapies for the treatment of pulmonary hypertension.
@nl
P1476
Emerging therapies for the treatment of pulmonary hypertension.
@en
P2093
Kurt R Stenmark
Marlene Rabinovitch
P304
P356
10.1097/PCC.0B013E3181C76DB3
P433
P577
2010-03-01T00:00:00Z